Hye-Rim Won

Hye-Rim Won

UNVERIFIED PROFILE

Are you Hye-Rim Won?   Register this Author

Register author
Hye-Rim Won

Hye-Rim Won

Publications by authors named "Hye-Rim Won"

Are you Hye-Rim Won?   Register this Author

7Publications

129Reads

48Profile Views

HDAC6‑selective inhibitor synergistically enhances the anticancer activity of immunomodulatory drugs in multiple myeloma.

Int J Oncol 2019 Aug 20;55(2):499-512. Epub 2019 Jun 20.

College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, Yonsei University, Incheon 21983, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ijo.2019.4828DOI Listing
August 2019

A452, an HDAC6-selective inhibitor, synergistically enhances the anticancer activity of chemotherapeutic agents in colorectal cancer cells.

Mol Carcinog 2018 10 22;57(10):1383-1395. Epub 2018 Jun 22.

College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, Yonsei University, Incheon, Republic of Korea.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/mc.22852
Publisher Site
http://dx.doi.org/10.1002/mc.22852DOI Listing
October 2018

The HDAC6 inhibitor ACY‑1215 enhances the anticancer activity of oxaliplatin in colorectal cancer cells.

Int J Oncol 2018 Aug 11;53(2):844-854. Epub 2018 May 11.

College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, Yonsei University, Incheon 21983, Republic of Korea.

View Article

Download full-text PDF

Source
http://www.spandidos-publications.com/10.3892/ijo.2018.4405
Publisher Site
http://dx.doi.org/10.3892/ijo.2018.4405DOI Listing
August 2018

A potent hydroxamic acid-based, small-molecule inhibitor A452 preferentially inhibits HDAC6 activity and induces cytotoxicity toward cancer cells irrespective of p53 status.

Carcinogenesis 2018 01;39(1):72-83

College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, Yonsei University, Incheon, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/bgx121DOI Listing
January 2018

Advances in epigenetic glioblastoma therapy.

Oncotarget 2017 Mar;8(11):18577-18589

College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, Yonsei University, Incheon, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.14612DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392350PMC
March 2017

HDAC6 regulates sensitivity to cell death in response to stress and post-stress recovery.

Cell Stress Chaperones 2017 03 23;22(2):253-261. Epub 2017 Jan 23.

College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, Yonsei University, 85 Songdogwahak-ro, Yeonsu-gu, Incheon, 21983, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12192-017-0763-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352599PMC
March 2017

Influence of toxicologically relevant metals on human epigenetic regulation.

Toxicol Res 2015 Mar;31(1):1-9

College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, Yonsei University, Incheon, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5487/TR.2015.31.1.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4395649PMC
March 2015